Developing precision oncology therapies for RAS-addicted cancers
| Title |
|---|
| Director, Discovery Sciences & Technologies Full Time · $211K-$264K · 8+ YOE Redwood City, California, United States · Onsite |
| Head of Legal Operations Full Time · $211K-$264K · 15+ YOE Redwood City, California, United States · Onsite |
| Clinical Program Manager Full Time · $143K-$178K · 8+ YOE Redwood City, California, United States · Onsite |
| Clinical Program Manager Full Time · $143K-$178K · 8+ YOE Redwood City, California, United States · Onsite |
| Global Development Lead (GDL) , Clinical Development – Lung Cancer Full Time · $369K-$424K · 13+ YOE Redwood City, California, United States · Hybrid |
| Associate Director, Regulatory Operations Full Time · $186K-$233K · 8+ YOE Redwood City, California, United States · Onsite |
| Senior Manager, Regulatory Operations (Records & Information Management) Full Time · $164K-$205K · 7+ YOE Redwood City, California, United States · Onsite |
| Associate Director, Omnichannel Full Time · $186K-$233K · 8+ YOE Redwood City, California, United States · Hybrid |
| Associate Director, Medical Analytics and Exploratory Data Science Full Time · $186K-$233K · 5+ YOE Redwood City, California, United States · Onsite |
| Associate Director, Medical Affairs Content and Training Full Time · $177K-$221K · 5+ YOE United States · Remote |
| Facilities Space Planner Full Time · $90K-$108K · 1+ YOE Redwood City, California, United States · Onsite |
| Senior HRIS Analyst Full Time · $120K-$150K · 6+ YOE Redwood City, California, United States · Onsite |
| Research Associate II, Biology Research Operations Full Time · $88K-$106K · 3+ YOE Redwood City, California, United States · Hybrid |
| Activities | Oncology drug developmentSmall molecule discoveryClinical trial executionTargeted therapy researchChemical biology development |
| Headquarters | US |
| Industries | BiotechnologyPharmaceuticals |
| Name | Revolution Medicines |
| Employees | 958 |
| Type | Public |
| Subsidiaries | Warp Drive BioRevolution Medicines UK |
| Tagline | Developing precision oncology therapies for RAS-addicted cancers |
| Founded | 2,014 |
| Website | revmed.com |
| Stock Exchange | NASDAQ |
| Stock Symbol | RVMD |